Internal Medicine · Los Alamitos, CA
NPI
1700882479
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
10941 Bloomfield St, Suite A
Los Alamitos, CA, 90720
Phone (562) 596-1667
Groups this clinician bills Medicare through
Medicare paid, 2024
$670K
9,316 services
Medicare patients, 2024
1,206
Average age 74
Drug cost, 2024
$2.6M
16,460 prescriptions
Company payments, 2025
$1,039
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jack Rubin was code 99233 (hospital e&m - subsequent), 3,136 times for 664 patients. In total Jack Rubin billed 9,316 services in 56 codes, and Medicare paid $670K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 3,136 | 664 | $88.74 | $278K |
| 99309 SNF E&M | Facility | 650 | 163 | $79.27 | $52K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 597 | 236 | $12.25 | $7,312 |
| 99457 E&M - Miscellaneous | Office | 473 | 75 | $38.21 | $18K |
| 99215 Office E&M - Established | Office | 441 | 222 | $115.18 | $51K |
| 99454 E&M - Miscellaneous | Office | 398 | 67 | $39.64 | $16K |
| 90962 ESRD Related Services (not dialysis) | Office | 361 | 89 | $153.88 | $56K |
| 99307 SNF E&M | Facility | 356 | 180 | $30.90 | $11K |
| 99214 Office E&M - Established | Office | 347 | 198 | $85.50 | $30K |
| 99458 E&M - Miscellaneous | Office | 298 | 65 | $29.99 | $8,937 |
| 99223 Hospital E&M - Initial | Facility | 210 | 195 | $129.73 | $27K |
| 90961 ESRD Related Services (not dialysis) | Office | 209 | 63 | $222.59 | $47K |
| 99309 SNF E&M | Office | 150 | 25 | $80.35 | $12K |
| 99091 E&M - Miscellaneous | Office | 104 | 60 | $40.68 | $4,231 |
| 99306 SNF E&M | Facility | 88 | 60 | $136.86 | $12K |
By year: 2022 $510K for 5,172 services; 2023 $641K for 6,104 services; 2024 $670K for 9,316 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 43 | 38 | $3.41 | $147 |
Medicare prescription drug claims, 2024
In 2024, the drug Jack Rubin prescribed most often to Medicare patients was Atorvastatin Calcium, with 728 prescriptions and refills. In total Jack Rubin wrote 16,460 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 728 | 1,181 | 139 | $7,090 |
| Amlodipine Besylate Generic | 545 | 853 | 112 | $3,440 |
| Jardiance Empagliflozin | 404 | 539 | 68 | $297K |
| Losartan Potassium Generic | 376 | 661 | 86 | $3,310 |
| Pantoprazole Sodium Generic | 367 | 563 | 74 | $11K |
| Gabapentin Generic | 318 | 348 | 57 | $4,522 |
| Eliquis Apixaban | 303 | 357 | 34 | $144K |
| Kerendia Finerenone | 280 | 358 | 53 | $222K |
| Farxiga Dapagliflozin Propanediol | 277 | 349 | 54 | $168K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 250 | 250 | 55 | $5,496 |
| Ozempic Semaglutide | 249 | 304 | 57 | $249K |
| Furosemide Generic | 245 | 342 | 54 | $1,780 |
| Metformin Hcl Generic | 244 | 393 | 49 | $1,933 |
| Carvedilol Generic | 241 | 382 | 48 | $1,599 |
| Levothyroxine Sodium Generic | 226 | 371 | 45 | $2,866 |
Brand drugs: 3,533 claims; generic drugs: 12,789 claims; opioid claims: 468.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jack Rubin $1,039 ($1,039 in general payments such as food, travel and fees) from 16 companies. The largest payer was Akebia Therapeutics Inc with $191.
| Company | Payments | Amount |
|---|---|---|
| Akebia Therapeutics Inc AKBA | 8 | $191 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 7 | $171 |
| Ardelyx, Inc. ARDX | 4 | $83.9 |
| Calliditas Therapeutics US Inc. | 3 | $80.86 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $77.2 |
| Novo Nordisk Inc NVO | 3 | $67.22 |
| Scpharmaceuticals Inc. SCPH | 3 | $66.71 |
| Aurinia Pharma U.S., Inc. AUPH | 3 | $58.03 |
| Apellis Pharmaceuticals, Inc. APLS | 2 | $50.7 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $33.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.